I. Introduction
Tendinopathy refers to a triad of pain, swelling and decreased activity. Tendon related injuries are classified as tendinitis during acute inflammatory process and tendinosis when the healing become chronically impaired, clinicians are increasingly using the term tendinopathy to refer tendon disorders without a specific pathology, and chronic tendinopathy for cases that are refractory to conventional treatment. Common tendinopathies are epicondylitis, rotator cuff tendinopathy, patellar tendinopahy, achilles tendinopathy These have traditionally been treated conservatively by activity restriction, nonsteroidal anti-inflammatory drugs, physical therapy and judicious use of orthotics. Unresponsive patients are being treated by locally acting steroid injections with varied results. Surgical options are used sparingly when indicated. Platelet rich plasma has been tried by various researchers with the aim of a biological cure with minimal side effects and has shown promising results.Sports related injuries among professional and recreational athletes are increasingly encountered and diagnosed and demand a quick return to preinjury level of sporting activities. 1 "Orthobiologics", refers to the use of biological substances to help musculoskeletal injuries heal quicker. They are used to improve the healing of fractured bones and injured muscles, tendons and ligaments and are derived from substances that are naturally found in body.
2 When they are used in concentrations many times the normal, they can potentially help speed up the healing processes. The substances include bone grafts, autologous blood, platelet-rich plasma (PRP), autologous conditioned serum and stem cells.
2 Bone grafts act by their osteoinductive, osteoconductive and osteogenic properties to stimulate new bone formation and have no effect on the healing of muscles, tendons and ligaments. 3 On the other hand, autologous blood, PRP and autologous conditioned serum deliver growth factors to the diseased areas to stimulate the repair process. [4] [5] [6] Platelet-rich plasma (PRP) is defined as a sample of autologous blood with concentrations of platelets above baseline values. 26 Platelets play an instrumental role in the normal healing response via the local secretion of growth factors and recruitment of reparative cells. 59 This study is conducted to know the effect of platelet rich plasma injection in the management of chronic tendinopathy in the Department of orthopaedics, M.K.C.G Medical College, Berhampur from 2014 to 2016. INFERENCE: There was significant difference of mean visual scores of pain in all given group pair (p value <0.05). Inference: There was significant difference of mean visual scores of pain in all given group pair (p value <0.05). INFERENCE: There was significant difference of mean visual scores of pain in all given RCT. INFERENCE: There was significant difference of mean visual scores of pain in all chronic tendinopathy.
In this study arbitrarily we assumed patient with visual analogue pain score equal or less than 3 as satisfactory improvement of pain. INFERENCE: On basis of Visual analogue pain score, satisfactory improvement of pain at 1 month, 3months and 6month post injection were observed in 4%, 50%and 84% of tendinopathies respectively.
Summary
A total of 50 patients presenting with complaints of chronic tendinopathies who did not respond to conservative treatment for 3 months were included in the study. 56% patients were male and 44 % patients were female.in our study 18 (36%), 9 (18%),12(24%) and 11(22 %) of total patients belong to lateral epicondylitis, medial epicondylitis, rotator cuff tendinopathy and Achilles tendinopathy respectively.In this study, 33 (66%) affected patients belong to right side and 17 (34%) affected patients to left side. Mean age of male patient"s was 42.39 ±6.14 year. Mean age of female patient"s was 41.89 ±5.6 year. Most common activity levels in male patients were heavy or longstanding and in female patients were sedentary. There are no significant differences of mean in male and female pain score groups at Pre-injection level.There was no DOI: 10.9790/0853-1605084151 www.iosrjournals.org 46 | Page significant mean difference in preinjection pain scores on basis daily activity level (p value >0.05).Mean visual analogue scores of all affected patients at 1 month, 3 month, and 6 month post-injection follow up showed improvement. Significant difference of mean visual scores of pain were observed. There was no significant mean difference in male and female patient"s pain score.These were no significant mean difference in right and left side pain scores.Satisfactory improvements were shown in 84% of tendinopathies at 6 month follow up on basis of VAS .Satisfactory and unsatisfactory improvement patients had similar profile like age, weight.
V. Conclusion
The results of this study indicate that PRP injection has a role to play in the management of chronic tendinopathies. This technique was efficient in approximately 84%affected patients at 6 month follow-up. PRP is simple to acquire and prepare and is also cost effective . Hence it provides satisfactory intermediate and long term results in term of pain relief. It seems a safe clinical procedure. Indeed we had no reported side effects. However larger data set and longer follow up are required to conclude definitive role of PRP. We believe that these initial encouraging results now warrant further investigation, in particular with the use of a prospective randomized controlled trial (RCT).
VI.

Limitations
There are some limitations of the study that should be considered.It is small no patients study, only 50 patients. Larger studies would be required to further validate efficacy of autologous platelet rich plasma injection in chronic tendinopathy with failed conservative management.This study did not include any control group for comparison of PRP injection result. Studies with control group of proven treatment modality would be required to further validate efficacy of PRP.In this study PRP preparation was done with ordinary technique. Further Studies with better PRP preparation technique would be required to further validate efficacy of PRP
VII. Discussion
Chronic tendinopathies are common clinical problem with many available treatment modalities. Traditional treatments include rest, analgesics and physiotherapy. Injections, particularly corticosteroids, are given in very acute situations and for cases unresponsive to conservative methods. Corticosteroids offer a quick fix for pain relief in the acute phase but have limited effect in chronic cases with a significant fraction of patients having relapse and recurrence 130 . In chronic cases, surgery is the last resort with very unpredictable results. Recent years have seen an increase in the use of PRP in various clinical situations like epicondylitis, rotator cuff, patellar and calcaneal tendinopathies, and proximal plantar fascitis. This study was designed to evaluate the efficacy of PRP therapy for chronic tendinopathy. PRP contains a more concentrated amount of platelets than does whole blood. The rationale for using PRP is to increase tendon regenerative abilities with a high content of cytokines and cells, in hyper-physiologic doses, which should promote cellular chemotaxis, matrix synthesis, and proliferation. 111 Degranulation of the alpha granules in platelets releases many different growth factors that can play a role in tissue regeneration processes. PRP represents a treatment option for many foot and ankle pathologies, including tendinopathy (Achilles, pe-roneal, posterior tibial, flexor hallucis longus, anterior tibial) and chronic ligamentous injury, such as plantar fascitis. 110 . Visual Analogue Scale (VAS) measure amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain. Operationally a VAS is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end. Peerbooms et al. 32 conducted a RCT with 100 patients lateral epicondylitis, 51 of whom received PRP injection and 49 received corticosteroid injections and reported better improvement with PRP over a period of 1 year. Gosens et al. 33 followed up these patients for the subsequent year and reported a sustained improvement with PRP use in comparison to corticosteroids. Thanasas et al. 17 have also shown encouraging results for PRP use compared to ABI in resistant tennis elbow patients.Randelli et al. 36 conducted an uncontrolled pilot study of PRP augmentation along with arthroscopic rotator cuff repair. In their 14 patients injected with PRP activated with thrombin at the tendon footprint after repair, they reported statistically significant improvements in VAS. Owens et al. 47 reported modest improvement in functional outcome in 10 patients who had received PRP injection for mid substance Achilles tendinopathy. Monto et al. 48 reported clinical success in 28 out of 30 patients with recalcitrant Achilles tendinosis. The improvement noted was in the AOFAS score and the MR architecture of the tendon.
The present series also shows significant improvement in VAS in consecutive follow up at 1 month, 3 month, and 6 month of duration for lateral epicondylitis medial epicondylitis and rotator cuff tendinopathy and Achilles tendinopathy. Differences between mean pain score on follow up were statistically significant in every follow up interval. These results are comparable to previous studies.It was assumed, that patients with visual analogue pain score equal or less than 3. On the basis of Visual analogue pain score, satisfactory improvement of pain were observed in 4%, 50%and 84% of tendons at 1 month, 3month and 6month post injection respectively.At final follow up (at 6 month) approx. 84 % of patient who received PRP in injection showed satisfactory improvementof pain.
Materials required
•Tourniquet
•Surgical gloves 
